The emerging role of synaptic cell-adhesion pathways in the pathogenesis of autism spectrum disorders
暂无分享,去创建一个
[1] Jens Frahm,et al. Reduced social interaction and ultrasonic communication in a mouse model of monogenic heritable autism , 2008, Proceedings of the National Academy of Sciences.
[2] Jamel Chelly,et al. Genetics and pathophysiology of mental retardation , 2006, European Journal of Human Genetics.
[3] S. Schwartz,et al. Terminal 22q deletion syndrome: a newly recognized cause of speech and language disability in the autism spectrum. , 2004, Pediatrics.
[4] T. Südhof,et al. α-Neurexins couple Ca2+ channels to synaptic vesicle exocytosis , 2003, Nature.
[5] L. Peltonen,et al. Analysis of four neuroligin genes as candidates for autism , 2005, European Journal of Human Genetics.
[6] A. El-Husseini,et al. A Preformed Complex of Postsynaptic Proteins Is Involved in Excitatory Synapse Development , 2006, Neuron.
[7] D. Pinto,et al. Structural variation of chromosomes in autism spectrum disorder. , 2008, American journal of human genetics.
[8] J. Pritchard. Are rare variants responsible for susceptibility to complex diseases? , 2001, American journal of human genetics.
[9] H. Kehrer-Sawatzki,et al. Molecular cytogenetic analysis of a familial interstitial deletion Xp22.2‐22.3 with a highly variable phenotype in female carriers , 2006, American journal of medical genetics. Part A.
[10] Kristen M Harris,et al. Dendritic Spine Pathology: Cause or Consequence of Neurological Disorders? , 2002, Brain Research Reviews.
[11] M. Ehlers,et al. Microanatomy of dendritic spines: emerging principles of synaptic pathology in psychiatric and neurological disease , 2004, Biological Psychiatry.
[12] H. Zoghbi. Postnatal Neurodevelopmental Disorders: Meeting at the Synapse? , 2003, Science.
[13] Kenny Q. Ye,et al. Strong Association of De Novo Copy Number Mutations with Autism , 2007, Science.
[14] P. Maness,et al. L1 and NCAM adhesion molecules as signaling coreceptors in neuronal migration and process outgrowth , 2008, Current Opinion in Neurobiology.
[15] M. Hallschmid,et al. Intranasal insulin to improve developmental delay in children with 22q13 deletion syndrome: an exploratory clinical trial , 2008, Journal of Medical Genetics.
[16] Guosong Liu,et al. Regulation of Dendritic Spine Morphology and Synaptic Function by Shank and Homer , 2001, Neuron.
[17] M. Tranfaglia,et al. Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP , 2005, Neuropharmacology.
[18] Charles E. Schwartz,et al. High frequency of neurexin 1β signal peptide structural variants in patients with autism , 2006, Neuroscience Letters.
[19] T. Südhof,et al. Activity-Dependent Validation of Excitatory versus Inhibitory Synapses by Neuroligin-1 versus Neuroligin-2 , 2007, Neuron.
[20] D. Conrad,et al. Recurrent 16p11.2 microdeletions in autism. , 2007, Human molecular genetics.
[21] Chris I. De Zeeuw,et al. Rescue of behavioral phenotype and neuronal protrusion morphology in Fmr1 KO mice , 2008, Neurobiology of Disease.
[22] S. Scherer,et al. Mutation screening of X‐chromosomal neuroligin genes: No mutations in 196 autism probands , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[23] H. Taniguchi,et al. Silencing of Neuroligin Function by Postsynaptic Neurexins , 2007, The Journal of Neuroscience.
[24] E. Lander,et al. On the allelic spectrum of human disease. , 2001, Trends in genetics : TIG.
[25] Y. Takai,et al. Nectin: an adhesion molecule involved in formation of synapses. , 2002, The Journal of cell biology.
[26] S. Itoh,et al. Nectin-like molecule-1/TSLL1/SynCAM3: a neural tissue-specific immunoglobulin-like cell-cell adhesion molecule localizing at non-junctional contact sites of presynaptic nerve terminals, axons and glia cell processes , 2005, Journal of Cell Science.
[27] Mochtar Pribadi,et al. Laminar and compartmental regulation of dendritic growth in mature cortex , 2009, Nature Neuroscience.
[28] R. Fetter,et al. Neuroligin Expressed in Nonneuronal Cells Triggers Presynaptic Development in Contacting Axons , 2000, Cell.
[29] M. Schachner,et al. Neural recognition molecules of the immunoglobulin superfamily: signaling transducers of axon guidance and neuronal migration , 2006, Nature Neuroscience.
[30] J. Sanes,et al. Gamma protocadherins are required for synaptic development in the spinal cord. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[31] P. Scheiffele,et al. Disorder-associated mutations lead to functional inactivation of neuroligins. , 2004, Human molecular genetics.
[32] Laurent Mottron,et al. Novel de novo SHANK3 mutation in autistic patients , 2009, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[33] Colin L. Stewart,et al. Juxtaparanodal clustering of Shaker-like K+ channels in myelinated axons depends on Caspr2 and TAG-1 , 2003, The Journal of cell biology.
[34] D. Gutmann,et al. Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex , 2008, Annals of neurology.
[35] A. Munnich,et al. Neurobehavioral Profile and Brain Imaging Study of the 22q13.3 Deletion Syndrome in Childhood , 2008, Pediatrics.
[36] P. Marynen,et al. Detection of genomic copy number changes in patients with idiopathic mental retardation by high‐resolution X‐array‐CGH: important role for increased gene dosage of XLMR genes , 2007, Human mutation.
[37] J. Stockman. Association between Microdeletion and Microduplication at 16p11.2 and Autism , 2009 .
[38] K. Mori,et al. Overlapping and differential expression of BIG-2, BIG-1, TAG-1, and F3: four members of an axon-associated cell adhesion molecule subgroup of the immunoglobulin superfamily. , 1995, Journal of neurobiology.
[39] F. Mochel,et al. Normal intelligence and social interactions in a male patient despite the deletion of NLGN4X and the VCX genes. , 2008, European journal of medical genetics.
[40] D. Geschwind,et al. Advances in autism genetics: on the threshold of a new neurobiology , 2008, Nature Reviews Genetics.
[41] H. Hoyme,et al. 22q13.3 deletion syndrome: A recognizable malformation syndrome associated with marked speech and language delay , 2007, American journal of medical genetics. Part C, Seminars in medical genetics.
[42] P. Chiurazzi,et al. XLMR genes: update 2007 , 2008, European Journal of Human Genetics.
[43] K. Reddy. Cytogenetic abnormalities and fragile-x syndrome in Autism Spectrum Disorder , 2005, BMC Medical Genetics.
[44] T. Südhof,et al. Dissection of Synapse Induction by Neuroligins , 2005, Journal of Biological Chemistry.
[45] Yiping Shen,et al. Disruption of neurexin 1 associated with autism spectrum disorder. , 2008, American journal of human genetics.
[46] Eric Fombonne,et al. Epidemiology of autistic disorder and other pervasive developmental disorders. , 2005, The Journal of clinical psychiatry.
[47] Z Josh Huang,et al. GABA and neuroligin signaling: linking synaptic activity and adhesion in inhibitory synapse development , 2008, Current Opinion in Neurobiology.
[48] D. Conrad,et al. Global variation in copy number in the human genome , 2006, Nature.
[49] Ann Marie Craig,et al. Neurexins Induce Differentiation of GABA and Glutamate Postsynaptic Specializations via Neuroligins , 2004, Cell.
[50] J. Frahm,et al. Neuroligin‐3‐deficient mice: model of a monogenic heritable form of autism with an olfactory deficit , 2009, Genes, brain, and behavior.
[51] Hidekazu Tanaka,et al. N-Cadherin Redistribution during Synaptogenesis in Hippocampal Neurons , 1998, The Journal of Neuroscience.
[52] L. Willatt,et al. X-linked ichthyosis (steroid sulfatase deficiency) is associated with increased risk of attention deficit hyperactivity disorder, autism and social communication deficits , 2008, Journal of Medical Genetics.
[53] V. Meiner,et al. Deletions of VCX-A and NLGN4: a variable phenotype including normal intellect. , 2007, Journal of intellectual disability research : JIDR.
[54] Nils Brose,et al. The complexity of PDZ domain-mediated interactions at glutamatergic synapses: a case study on neuroligin , 2004, Neuropharmacology.
[55] T. Südhof,et al. Postsynaptic N-methyl-D-aspartate receptor function requires alpha-neurexins. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[56] P. Heutink,et al. CNTNAP2 is disrupted in a family with Gilles de la Tourette syndrome and obsessive compulsive disorder. , 2003, Genomics.
[57] R. Jaenisch,et al. Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2 , 2007, Proceedings of the National Academy of Sciences.
[58] 杉山 佳子. Determination of absolute protein numbers in single synapses by a GFP-based calibration technique , 2005 .
[59] Andrew Menzies,et al. X-linked protocadherin 19 mutations cause female-limited epilepsy and cognitive impairment , 2008, Nature Genetics.
[60] D. Karagogeos. Neural GPI-anchored cell adhesion molecules. , 2003, Frontiers in bioscience : a journal and virtual library.
[61] C. Hoogenraad,et al. The postsynaptic architecture of excitatory synapses: a more quantitative view. , 2007, Annual review of biochemistry.
[62] Shiaoching Gong,et al. Minimal aberrant behavioral phenotypes of neuroligin‐3 R451C knockin mice , 2008, Autism research : official journal of the International Society for Autism Research.
[63] T. Südhof,et al. Neuroligin 1: a splice site-specific ligand for beta-neurexins. , 1995, Cell.
[64] Thomas Bourgeron,et al. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders , 2007, Nature Genetics.
[65] K. Nolan,et al. Analysis of protocadherin alpha gene deletion variant in bipolar disorder and schizophrenia , 2008, Psychiatric genetics.
[66] J. Constantino,et al. Familial aggregation of quantitative autistic traits in multiplex versus simplex autism , 2009, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[67] Nathan R. Wilson,et al. Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice , 2009, Proceedings of the National Academy of Sciences.
[68] Jyothi Arikkath,et al. Cadherins and catenins at synapses: roles in synaptogenesis and synaptic plasticity , 2008, Trends in Neurosciences.
[69] A. Klin,et al. Disruption of contactin 4 (CNTN4) results in developmental delay and other features of 3p deletion syndrome. , 2004, American journal of human genetics.
[70] L. Tsai,et al. Cdk5 Promotes Synaptogenesis by Regulating the Subcellular Distribution of the MAGUK Family Member CASK , 2007, Neuron.
[71] E. Isacoff,et al. Neurexin mediates the assembly of presynaptic terminals , 2003, Nature Neuroscience.
[72] Rodney Cotterill,et al. Mutation screening and association analysis of six candidate genes for autism on chromosome 7q , 2005, European Journal of Human Genetics.
[73] Jacqueline Blundell,et al. A Neuroligin-3 Mutation Implicated in Autism Increases Inhibitory Synaptic Transmission in Mice , 2007, Science.
[74] A. Bird,et al. Reversal of Neurological Defects in a Mouse Model of Rett Syndrome , 2007, Science.
[75] Katarzyna Chawarska,et al. Molecular cytogenetic analysis and resequencing of contactin associated protein-like 2 in autism spectrum disorders. , 2008, American journal of human genetics.
[76] Eric M. Morrow,et al. Identifying Autism Loci and Genes by Tracing Recent Shared Ancestry , 2008, Science.
[77] Robert T. Schultz,et al. Autism genome-wide copy number variation reveals ubiquitin and neuronal genes , 2009, Nature.
[78] Thomas C. Südhof,et al. Neuroligins Determine Synapse Maturation and Function , 2006, Neuron.
[79] Laurent Mottron,et al. NLGN3/NLGN4 gene mutations are not responsible for autism in the Quebec population , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[80] P. Scheiffele. Cell-cell signaling during synapse formation in the CNS. , 2003, Annual review of neuroscience.
[81] J. Lilien,et al. Alterations in CDH15 and KIRREL3 in patients with mild to severe intellectual disability. , 2008, American journal of human genetics.
[82] J A Veltman,et al. CNTNAP2 gene dosage variation is associated with schizophrenia and epilepsy , 2008, Molecular Psychiatry.
[83] Igor Tsigelny,et al. The Arg451Cys-Neuroligin-3 Mutation Associated with Autism Reveals a Defect in Protein Processing , 2004, The Journal of Neuroscience.
[84] R. Giorda,et al. Identification of a recurrent breakpoint within the SHANK3 gene in the 22q13.3 deletion syndrome , 2005, Journal of Medical Genetics.
[85] Hidekazu Tanaka,et al. γ-Protocadherins Are Targeted to Subsets of Synapses and Intracellular Organelles in Neurons , 2003, The Journal of Neuroscience.
[86] J. Pritchard,et al. The allelic architecture of human disease genes: common disease-common variant...or not? , 2002, Human molecular genetics.
[87] S. Christian,et al. Disruption of Contactin 4 in 3 Subjects with Autism Spectrum Disorder , 2008 .
[88] Wei Zhang,et al. Pharmacological Inhibition of mTORC1 Suppresses Anatomical, Cellular, and Behavioral Abnormalities in Neural-Specific Pten Knock-Out Mice , 2009, The Journal of Neuroscience.
[89] T. Südhof,et al. Extracellular Domains of α-Neurexins Participate in Regulating Synaptic Transmission by Selectively Affecting N- and P/Q-Type Ca2+ Channels , 2005, The Journal of Neuroscience.
[90] D. Stephan,et al. Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2. , 2006, The New England journal of medicine.
[91] T. Südhof,et al. Deletion of α‐neurexins does not cause a major impairment of axonal pathfinding or synapse formation , 2007, The Journal of comparative neurology.
[92] N. Kato,et al. Association of the neuronal cell adhesion molecule (NRCAM) gene variants with autism. , 2009, The international journal of neuropsychopharmacology.
[93] T. Sakurai,et al. Activity-Induced Protocadherin Arcadlin Regulates Dendritic Spine Number by Triggering N-Cadherin Endocytosis via TAO2β and p38 MAP Kinases , 2007, Neuron.
[94] Richard P Lifton,et al. Disruption of Contactin 4 (CNTN4) results in developmental delay and other features of 3p deletion syndrome. , 2004, American journal of human genetics.
[95] Mark F Bear,et al. The mGluR theory of fragile X mental retardation , 2004, Trends in Neurosciences.
[96] Elvira Bramon,et al. Disruption of the neurexin 1 gene is associated with schizophrenia. , 2009, Human molecular genetics.
[97] M. Rieder,et al. Mutations of CASK cause an X-linked brain malformation phenotype with microcephaly and hypoplasia of the brainstem and cerebellum , 2008, Nature Genetics.
[98] K. Strauch,et al. No evidence for involvement of genetic variants in the X‐linked neuroligin genes NLGN3 and NLGN4X in probands with autism spectrum disorder on high functioning level , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[99] Albert David,et al. X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family. , 2004, American journal of human genetics.
[100] C. Redies,et al. Cadherins as regulators for the emergence of neural nets from embryonic divisions , 2003, Journal of Physiology-Paris.
[101] R. Borgatti,et al. Disruption of the ProSAP2 gene in a t(12;22)(q24.1;q13.3) is associated with the 22q13.3 deletion syndrome. , 2001, American journal of human genetics.
[102] S. Kenwrick,et al. Neural cell recognition molecule L1: relating biological complexity to human disease mutations. , 2000, Human molecular genetics.
[103] P. Scheiffele,et al. Control of Excitatory and Inhibitory Synapse Formation by Neuroligins , 2005, Science.
[104] S. Christian,et al. Disruption of contactin 4 in three subjects with autism spectrum disorder , 2008, Journal of Medical Genetics.
[105] P. Maness,et al. NCAM in Neuropsychiatric and Neurodegenerative Disorders , 2008, Neurochemical Research.
[106] S. Sommer,et al. Familial deletion within NLGN4 associated with autism and Tourette syndrome , 2008, European Journal of Human Genetics.
[107] T. Boeckers,et al. The postsynaptic density , 2006, Cell and Tissue Research.
[108] L. Larizza,et al. Mutations and novel polymorphisms in coding regions and UTRs of CDK5R1 and OMG genes in patients with non-syndromic mental retardation , 2006, Neurogenetics.
[109] T. Südhof. Neuroligins and neurexins link synaptic function to cognitive disease , 2008, Nature.
[110] T. Südhof,et al. Extracellular domains of alpha-neurexins participate in regulating synaptic transmission by selectively affecting N- and P/Q-type Ca2+ channels. , 2005, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[111] J. Girault,et al. Association of TAG-1 with Caspr2 is essential for the molecular organization of juxtaparanodal regions of myelinated fibers , 2003, The Journal of cell biology.
[112] Alcino J. Silva,et al. Reversal of learning deficits in a Tsc2+/− mouse model of tuberous sclerosis , 2008, Nature Medicine.
[113] B. D. de Vries,et al. 3q29 microdeletion syndrome: clinical and molecular characterization of a new syndrome. , 2005, American journal of human genetics.
[114] W. Bodmer,et al. Common and rare variants in multifactorial susceptibility to common diseases , 2008, Nature Genetics.
[115] B. Philpot,et al. No effect of genetic deletion of contactin‐associated protein (CASPR) on axonal orientation and synaptic plasticity , 2007, Journal of neuroscience research.
[116] C. Skinner,et al. Neurexin 1α structural variants associated with autism , 2008, Neuroscience Letters.
[117] E. Bacchelli,et al. Absence of coding mutations in the X‐linked genes neuroligin 3 and neuroligin 4 in individuals with autism from the IMGSAC collection , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[118] N. Craddock,et al. Analysis of the neuroligin 3 and 4 genes in autism and other neuropsychiatric patients , 2005, Molecular Psychiatry.
[119] Z. Talebizadeh,et al. Novel splice isoforms for NLGN3 and NLGN4 with possible implications in autism , 2005, Journal of Medical Genetics.
[120] Disorder and Schizophrenia , 1979 .
[121] R. Singer,et al. A direct role for FMRP in activity-dependent dendritic mRNA transport links filopodial-spine morphogenesis to fragile X syndrome , 2008, International Journal of Developmental Neuroscience.
[122] Elena B. Pasquale,et al. Molecular mechanisms of dendritic spine development and remodeling , 2005, Progress in Neurobiology.
[123] N. Minshew,et al. The new neurobiology of autism: cortex, connectivity, and neuronal organization. , 2007, Archives of neurology.
[124] G. Kirov,et al. Phenotypic variations on the theme of CNVs , 2008, Nature Genetics.
[125] J. Buxbaum,et al. Association analysis of the NrCAM gene in autism and in subsets of families with severe obsessive–compulsive or self-stimulatory behaviors , 2006, Psychiatric genetics.
[126] Christian R Marshall,et al. Contribution of SHANK3 mutations to autism spectrum disorder. , 2007, American journal of human genetics.
[127] P. Worley,et al. Shank Expression Is Sufficient to Induce Functional Dendritic Spine Synapses in Aspiny Neurons , 2005, The Journal of Neuroscience.
[128] Roberto Ciccone,et al. A 12Mb deletion at 7q33-q35 associated with autism spectrum disorders and primary amenorrhea. , 2008, European journal of medical genetics.
[129] Thomas Bourgeron,et al. Mapping autism risk loci using genetic linkage and chromosomal rearrangements , 2007, Nature Genetics.
[130] Shigeo Okabe,et al. Molecular anatomy of the postsynaptic density , 2007, Molecular and Cellular Neuroscience.
[131] H. McDermid,et al. Molecular characterisation of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3/PROSAP2 in the major neurological symptoms , 2003, Journal of medical genetics.
[132] M. Merzenich,et al. Model of autism: increased ratio of excitation/inhibition in key neural systems , 2003, Genes, brain, and behavior.
[133] D. Loesch,et al. Autism Spectrum Phenotype in Males and Females with Fragile X Full Mutation and Premutation , 2007, Journal of autism and developmental disorders.
[134] Thomas Bourgeron,et al. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism , 2003, Nature Genetics.
[135] J. Sebat,et al. Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene. , 2008, American journal of human genetics.
[136] J M Friedman,et al. A patient with vertebral, cognitive and behavioural abnormalities and a de novo deletion of NRXN1α , 2007, Journal of Medical Genetics.
[137] J. Powell,et al. Molecular and phenotypic characterization of ring chromosome 22 , 2005, American journal of medical genetics. Part A.
[138] Stephen T Warren,et al. Fragile X mental retardation protein deficiency leads to excessive mGluR5-dependent internalization of AMPA receptors , 2007, Proceedings of the National Academy of Sciences.
[139] Joseph Piven,et al. Defining key features of the broad autism phenotype: A comparison across parents of multiple‐ and single‐incidence autism families , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[140] A. El-Husseini,et al. Cell adhesion molecules at the synapse. , 2006, Frontiers in bioscience : a journal and virtual library.
[141] Mark F Bear,et al. Smaller Dendritic Spines, Weaker Synaptic Transmission, but Enhanced Spatial Learning in Mice Lacking Shank1 , 2008, The Journal of Neuroscience.
[142] Tanya M. Teslovich,et al. A common genetic variant in the neurexin superfamily member CNTNAP2 increases familial risk of autism. , 2008, American journal of human genetics.
[143] S. Fatemi,et al. Reelin glycoprotein: structure, biology and roles in health and disease , 2005, Molecular Psychiatry.
[144] Mark F. Bear,et al. Correction of Fragile X Syndrome in Mice , 2007, Neuron.
[145] Robert T. Schultz,et al. Common genetic variants on 5p14.1 associate with autism spectrum disorders , 2009, Nature.